Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
6.51
-0.02 (-0.31%)
At close: Jul 19, 2024, 4:00 PM
6.57
+0.06 (0.92%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $644.67 million as of July 22, 2024. Its market cap has decreased by -66.86% in one year.
Market Cap
644.67M
Enterprise Value
-32.74M
1-Year Change
-66.86%
Ranking
Category
Stock Price
$6.51
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $644.67M, a decrease of -61.36%. That is a compound annual growth rate of -54.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 644.70M | -11.22% |
| Dec 29, 2023 | 726.20M | -56.48% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aveanna Healthcare Holdings | 661.78M |
| Mineralys Therapeutics | 655.36M |
| Fulgent Genetics | 652.95M |
| UroGen Pharma | 650.07M |
| Exscientia | 649.15M |
| Arcturus Therapeutics Holdings | 640.71M |
| Phathom Pharmaceuticals | 640.67M |
| Prime Medicine | 636.76M |